Update shared on15 Aug 2025
Fair value Decreased 15%Despite a notable improvement in TruBridge’s net profit margin and a significant decline in its future P/E ratio, the consensus analyst price target has been sharply revised down from $29.25 to $24.75.
What's in the News
- TruBridge lowered its full-year 2025 revenue guidance to $345 million-$350 million from a previous range of $345 million-$360 million; third quarter 2025 revenue is forecasted at $85 million-$87 million.
- Jackson Parish Hospital returned as a client, deploying TruBridge’s Complete Business Office technology-enabled services to enhance financial operations.
- TruBridge replaced Grant Thornton LLP with KPMG LLP as its independent registered public accounting firm for fiscal year 2025.
- The company completed the integration of Microsoft Dragon Copilot into its EHR solution, expanding advanced AI speech and operational efficiencies to over 18,000 users.
- TruBridge was added to multiple Russell Growth and Small Cap indexes, while being dropped from several Value benchmarks.
Valuation Changes
Summary of Valuation Changes for TruBridge
- The Consensus Analyst Price Target has significantly fallen from $29.25 to $24.75.
- The Net Profit Margin for TruBridge has significantly risen from 6.89% to 9.92%.
- The Future P/E for TruBridge has significantly fallen from 21.31x to 12.79x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.